Latest Genomics News

Get Involved: the Salary Survey is Now Open for Life ScienceHelp The Scientist compile the latest data on salaries within the life-science community. New York, NY (PRWEB) May 25, 2012 The Scientist’s annual Salary Survey is now open to the life science community. With the help of researchers, the magazine provides insights into how salaries from various specialties and fields range in this dynamic industry. Responses are used to compile the most up-...

Genomics in Maternal Child HealthJoin NHGRI June 1 when Barbara Biesecker, Ph.D., NHGRI Social and Behavioral Research Branch, delivers a presentation entitled Genomics in Maternal Child Health. The lecture, which explores the implications of diagnostic prenatal testing, is part of...

Study Validating miRview mets2 Published in The Oncologist PHILADELPHIA, PA and REHOVOT, ISRAEL -- (Marketwire) -- 05/25/12 -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, today announced that data from studies of miRview® mets² in patients with Cancer of Unknown and Uncertain Primary ("CUP") were published online in The Oncologist in an article titled, "A second generation microR...

Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae StrainsLA JOLLA, Calif., May 24, 2012 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company commercializing and developing genomic-driven solutions to solve a range of global challenges, today announced they have purchased an 81 acre site for scale up and testing of newly identified and engineered algal strains. The company will use the site, located in the Imperial Valley near the Salt...

Blueprint Medicines Welcomes Fidelity Biosciences to Investor SyndicateBlueprint Medicines today announced that new investor Fidelity Biosciences joined existing founding investor Third Rock Ventures in its previously announced $40 million Series A financing. “Blueprint has recruited exceptional talent and created an organization with a real opportunity to transform cancer dr

Cellectricon Launches Cellaxess® Elektra Discovery PlatformGOTHENBURG, Sweden, May 24, 2012 /PRNewswire/ -- Cellectricon is pleased to announce the new Cellaxess Elektra Discovery Platform which represents a revolutionary development in automated electric field manipulation of adherent cells. Developed in close collaboration with leading pharmaceutical and biotechnology companies, the platform is highly diverse and can be applied to a wide variety of cel...

New genetic method pinpoints geographic origin(Medical Xpress) -- Understanding the genetic diversity within and between populations has important implications for studies of human disease and evolution. This includes identifying associations between genetic variants and disease, detecting geno...

Oryzon Nominates Specific LSD1 Inhibitor as Drug Candidate to Enter Preclinical Development in Acute Leukemia and Other Hematological CancersOryzon announced today that it is entering preclinical development with its second drug candidate, a first-in-class specific Lysine Specific Demethylase 1 (LSD1) inhibitor for the treatment of hematological cancers. LSD1 inhibition reduced tumor load especially in acute leukemia models by targeting Leukemia Stem Cells, while normal myeloid progenitor cells were spared. Barcelona, Spain (PRWEB) May...

Rosetta Genomics to Raise $6.6 Million in Registered Direct Offering PHILADELPHIA, PA and REHOVOT, ISRAEL -- (Marketwire) -- 05/24/12 -- Rosetta Genomics Ltd. ("Rosetta") (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced it has entered into definitive agreements with investors to purchase an aggregate of 570,755 ordinary shares at a price of $11.50 per share in a registered direct offering. The offering is e...

DNA Methylomes And ObesityIn a highlighted paper published online in Nature Communications, researchers from Sichuan Agricultural University and BGI, the world's largest genomics organization, reported the atlas of DNA methylomes in porcine adipose and muscle tissues, providi...

Whole genome sequencing of rare olfactory neuroblastomaThe Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have conducted whole genome sequencing (WGS) of a rare nasal tract cancer called olfactory neuroblastoma (ONB).

Janssen Healthcare Innovation Announces Discharge Decision Support System (D2S2) Winner of the Janssen Connected Care ChallengeSAN DIEGO, May 23, 2012 /PRNewswire/ -- Janssen Healthcare Innovation, a team within Janssen Research & Development, LLC (Janssen), today announced Discharge Decision Support System (D2S2) is the winner of the crowdsourcing-inspired Janssen Connected Care Challenge and the $100,000 prize. D2S2 is a discharge decision support system that uses a proprietary algorithm to assemble and score...

Cold Spring Harbor Laboratory Joins the Illumina Genome NetworkIllumina, Inc. (NASDAQ:ILMN) today announced that the Cold Spring Harbor Laboratory (CSHL) has joined the Illumina Genome Network (IGN) to provide researchers with broader access to whole genome sequencing (WGS) services. IGN and CSHL will work in collaboration to bring together CSHL’s expertise in molecular biology and cancer genomics with Illumina’s...

MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & SullivanLONDON, May 23, 2012 /PRNewswire/ -- A number of large pharmaceutical and biotech companies are keen to invest in life science research. Advances in genomic technologies and molecular biology segments will boost the microRNA (miRNA) research and tools market in the future. MicroRNA is set to unveil a new era in molecular diagnostics and in the development of effective therapeutics. New analy...

MicroRNA Research to Trigger Tremendous Growth in Related Tools Market, Says Frost & SullivanLONDON, May 23, 2012 /- A number of large pharmaceutical and biotech companies are keen to invest in life science research. Advances in genomic technologies and molecular biology segments will boost the microRNA (miRNA) research and tools market...

TGen-Scottsdale Healthcare conduct whole genome sequencing of rare olfactory neuroblastoma(The Translational Genomics Research Institute) The Translational Genomics Research Institute and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have conducted whole genome sequencing of a rare nasal tract cancer called olfactory neurob...

GeneLink Reports First Quarter 2012 Financial ResultsORLANDO, Fla., May 22, 2012 /PRNewswire/ -- GeneLink, Inc. (OTCBB: GNLK.OB, "the Company," or "GeneLink"), a leading consumer genomics biotech company, reports financial results for the three months ended March 31, 2012. Financial Results: On February 10, 2012 the Company closed on the sale of its direct selling subsidiary, GeneWize Life Sciences, Inc., consummating a transaction entered i...

California Healthcare Institute Announces Agenda and Speakers for Cancer Policy ProgramDana Goldman, Ph.D., to Keynote July Event in Los Angeles LA JOLLA, Calif. (PRWEB) May 22, 2012 Today, CHI-California Healthcare Institute announced the speakers and agenda for its upcoming event dedicated to cancer research and public health policy, “California: Uniting Science & Policy to Advance Cancer Care.” In 2012, nearly 144,800 Californians will be diagnosed with cancer, accordin...

Early Bird Discounts Available on International Healthcare and Biotechnology Conferences, Save Up To $600 with Global InformationFARMINGTON, Conn., May 22, 2012 /PRNewswire-iReach/ -- Global Information Inc is pleased to announce limited available early bird discounted registration for three significant international healthcare conferences: 2nd Annual World Health Care Congress – Latin America October 29-30, 2012 - Sao Paulo, Brazil – The 2nd Annual World Health Care Congress – Latin America builds on a...

BioTime and Subsidiary LifeMap Sciences, Inc. Announce Agreement to Market MalaCards - A Database of Human DiseasesBioTime, Inc. (NYSE MKT: BTX) today announced that its subsidiary LifeMap Sciences, Inc. has entered into a license agreement with Yeda Research and Development Company Ltd, the technology transfer arm of the Weizmann Institute of Science, to market a new database called MalaCards. A database of human diseases that is based on the GeneCards® platform, Mal...

New York Genome Center Announces Formal Commencement of Collaborative Relationship with IlluminaNew York Genome Center (NYGC) today announced the formal commencement of their collaborative relationship with Illumina, initiated in November 2011, when Illumina was selected as the Center’s lead sequencing technology provider. As a next step in this collaboration, the Center will begin taking delivery of Illumina HiSeq 2000 and 2500 sequencing systems,...

Selexis Co-Founder to Deliver Keynote Presentation at the 8th Annual Cell Line Development & Engineering Conference in San FranciscoNicolas Mermod, PhD, Professor of Biotechnology at Faculty of Biology and Medicine of the University of Lausanne, will present new and unpublished data in his presentation, “Putting the CHO Genome to Work: Illustrations to Increase Transgene Integration and Expression and to Improve Protein Processing” Geneva, Switzerland (PRWEB) May 22, 2012 Selexis SA, a global life sciences company for dru...

US-Based Everist Genomics Bucks the Outsourcing Trend and Accelerates Growth Through IndiaANN ARBOR, Mich., May 22, 2012 /PRNewswire/ -- Everist Genomics (EGI), a rapidly growing personalized medicine company, announced today that it has established a joint-venture company with the Manipal Group, one of the three largest healthcare sector companies in India. The joint venture will market EGI's portfolio of diagnostic, prognostic and therapeutic selection technologies in Indi...

Sichuan Agricultural University and BGI to unravel the relation between DNA methylomes and obesity(BGI Shenzhen) In a highlighted paper published online in Nature Communications, researchers from Sichuan Agricultural University and BGI, the world's largest genomics organization, reported the atlas of DNA methylomes in porcine adipose and muscle t...

Structure of mammalian poly(ADP-ribose) glycohydrolase reveals a flexible tyrosine clasp as a substrate-binding elementPoly ADP-ribosylation regulates cellular processes such as genomic stability maintenance, transcription and cell death. The structure of a mammalian poly(ADP-ribose) glycohydrolase gives insight into the enzyme's endoglycosidase activity and provides...

0 1 2 3 4 ›»

buy Genomics market research data and corporate reports now Advertisement